Rail Vikas Nigam, Sandu Pharmaceuticals and Zydus Lifesciences to see some action today

12 Dec 2022 Evaluate

Rail Vikas Nigam (RVNL) has formed a Joint Venture Company with Kyrgyzindustry - OJSC. The JV is for Construction of Rail road and other infrastructure projects in Kyrgyz Republic.

Sandu Pharmaceuticals has entered into Memorandum of understanding between Sandu Pharmaceuticals and BACH MA VAN XUAN PHARMACEUTICALS dated 10.12.2022. The purpose of this MOU is to further business relationship and to broaden the scope between two Companies in Vietnam and India. Specifically Bach Ma Van Xuan Company brings Sandus traditional medicine and cosmetic products to distribution in vietam.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Silodosin Capsules, 4 mg and 8 mg (USRLD: Rapaflo capsules). The company also received the final approval to market Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg (USRLD: Lyrica capsules).

PTC India Financial Services (PFS) has sanctioned additional loans of Rs 800 crore to various borrowers. The company is committed to perform better in coming quarters to achieve sustainable growth. Earlier, the company’s Board had sanctioned proposal of aggregate Rs 595 crore which shall be utilized for solar and other infrastructure projects.

Vodafone Idea (Vi) in partnership with Pariksha is offering study material, live virtual classes and mock tests for Madhya Pradesh (MP) Patwari exam syllabus on the Vi Jobs & Education platform on the Vi App. In addition, it is also offering study material across all syllabus subjects such as Science, Hindi, English, Mathematics, General Knowledge, Computer Knowledge, Reasoning Ability and General Management, on the Vi App.

Aavas Financiers has increased its AFL Prime Lending Rate (PLR) by 35 basis points. This increase is with effect from January 05, 2023. Earlier, the company had been awarded the Best Non-Banking Financial Company (NBFC) for the year 2020-21 in Financial Express India’s Best Banks Awards 2022.

Himatsingka Seide is planning to raise funds not exceeding $13 million (Equivalent to approximately Rs 108 crore) by way of issuance of inter alia equity shares, foreign currency convertible bonds, global depository receipts, American depository receipts and/ or any other instruments convertible into equity shares. The company is also planning to issue non-convertible debentures for an amount not exceeding Rs 500 crore, to identified investors.

Himatsingka Seide Share Price

116.90 -0.80 (-0.68%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Welspun Living 134.85
Vardhman Textiles 433.30
Arvind 331.55
K.P.R. Mill 979.75
Page Industries 37457.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×